PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Experimental Diabetes and Obesity Drug Shows Positive Results

A new experimental drug from Novo Nordisk has demonstrated significant weight loss and lower blood sugar levels in trials, including phase 2 trials conducted in China, showing positive results for diabetes and obesity treatment, as further confirmed by recent reports.

25 Mar, 07:19 — 25 Mar, 07:19
PostShare

Sources

Showing 1 of 4 sources
wsjHigh137d ago

Novo Nordisk Says Experimental Diabetes and Obesity Drug Shows Positive Results - WSJ

Novo Nordisk Says Experimental Diabetes and Obesity Drug Shows Positive Results  WSJ

Read full article →

Coverage Timeline

First report: berlingske · 25 Mar, 06:45Full coverage: 4 · 51mWindow: 51m
Left-leaningCenterRight-leaning
berlingske25 Mar, 06:45First to report

Nyt Novo-middel viser reduktion i vægt og blodsukker i Kina

wsj25 Mar, 07:19

Novo Nordisk Says Experimental Diabetes and Obesity Drug Shows Positive Results - WSJ

politiken25 Mar, 07:25

Nyt Novo-middel viser reduktion i vægt og blodsukker i Kina

dr-dk25 Mar, 07:37Latest update

Nyt Novo-middel viser fald i vægt og blodsukker i fase 2-studie i Kina

Related Stories

Volkswagen Employs More People Than Toyota Despite Lower Production

11m ago

Nvidia and Micron Drive S&P 500 to Record Highs

20m ago

India Achieves 300 GW Non-Fossil Power Capacity Milestone

22m ago

Europe Begins Lithium Mining in Finland

26m ago